Related Experiment Video
Updated: Aug 11, 2026
11:47
A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 9, 2014
Estrogen effects on protein expressed by marrow stromal osteoblasts
1Department of Cell Biology and Histology, Sackler Faculty of Medicine, Tel-Aviv University, Israel.
Biochemical and Biophysical Research Communications
|April 7, 1997
Summary
Estrogen treatment reduced key proteins in osteoblastic cells. This study monitored changes in cytoskeletal and membrane proteins, finding a decrease in tubulin, tropomyosin, actin, and a specific osteogenic cell antigen.
Area of Science:
- Cell Biology
- Endocrinology
- Biochemistry
Background:
- Osteoblastic cells are crucial for bone formation and remodeling.
- Estrogen plays a significant role in regulating bone metabolism.
- Understanding estrogen's cellular effects on osteoblasts is vital for bone health research.
Purpose of the Study:
- To investigate the impact of estrogen treatment on protein expression in osteoblastic MBA-15 cells.
- To identify specific proteins affected by estrogen in these marrow stromal-derived cells.
Main Methods:
- Osteoblastic MBA-15 cells were treated with 17beta-Estradiol.
- Cell lysates were fractionated into soluble, cytoskeleton, membrane/nuclei, and intermediate filament components.
- Proteins were analyzed using SDS-PAGE and radiolabeling with [35S]-Methionine.
- Western blot analysis and fluorescein staining were employed to assess protein expression.
Main Results:
- Estrogen treatment led to a reduction in the expression of cytoskeletal proteins, including tubulin (TUB) and tropomyosin (TM).
- A decrease in actin expression was observed via fluorescein staining.
- Expression of a specific osteogenic cell antigen (detected by MoAb 85/12) was also reduced.
Conclusions:
- 17beta-Estradiol treatment significantly alters protein expression in osteoblastic MBA-15 cells.
- Estrogen diminishes the levels of key cytoskeletal proteins and an osteogenic cell marker, suggesting a role in regulating osteoblast function.
Related Concept Videos
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:19Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:28Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...